Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Patients with diabetes are at higher risk for severe illness from COVID-19

(2020) G. Targher et al.   DIABETES & METABOLISM

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

(2020) Yuchen Chen et al.   DIABETES CARE

Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study

(2020) Qiao Shi et al.   DIABETES CARE

Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?

(2020) Celestino Sardu et al.   DIABETES CARE

Exposure to DPP ‐4 inhibitors and COVID ‐19 among people with type 2 diabetes. A case–control study

(2020) Gian Paolo Fadini et al.   DIABETES OBESITY & METABOLISM

Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study

(2020) Yan Zhang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)

(2020) Sandro Gentile et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Diabetes is a risk factor for the progression and prognosis of COVID-19

(2020) Weina Guo et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

(2020) Matthew J Cummings et al.   LANCET

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next

(2020) Angeliki M. Angelidi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Spread of SARS-CoV-2 in the Icelandic Population

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

(2020) Giuseppe Mancia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and impact of diabetes among people infected with SARS-CoV-2

(2020) G. P. Fadini et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends

(2020) Antonio Carlo Bossi et al.   Diabetes Therapy

Clinical characteristics and prognostic factors in COVID‐19 patients aged ≥80 years

(2020) Marcello Covino et al.   Geriatrics & Gerontology International

Age and Multimorbidity Predict Death Among COVID-19 Patients

(2020) Guido Iaccarino et al.   HYPERTENSION

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York

(2020) Leonidas Palaiodimos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease

(2018) Fabrice Bonnet et al.   DIABETES & METABOLISM

Pathophysiology and management strategies for hyperglycemia for patients with acute illness during and following a hospital stay

(2012) Nicole C. Dombrowski et al.   METABOLISM-CLINICAL AND EXPERIMENTAL